FDA Drug Application (021437) for INSPRA by GD SEARLE LLC

Back to FDA Applications sponsored by GD SEARLE LLC

Application Number021437
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameINSPRA
Active IngredientEPLERENONE

Active IngredientCount
List of drugs with Active Ingredient EPLERENONE2


Back to FDA Applications sponsored by GD SEARLE LLC